SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Linkage Global (UZX) — Dec 16, 2025

Linkage Global Inc
Date: Dec. 16, 2025 · CIK: 0001969401 · Accession: 0001213900-25-122474

Offering / Registration Process Financial Reporting Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289688

Referenced dates: December 11, 2025

Date
December 17, 2025
Author
Ross D. Carmel, Esq.
Form
CORRESP
Company
Linkage Global Inc

Letter

Via EDGAR Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission Attn.: Rucha Pandit Mara Ransom Re: Linkage Global Inc Response to the Staff's Comments on Amendment No. 1 to Registration Statement on Form F-1 Filed on October 9, 2025 (File No. 333-289688)

Dear Sir and Madam:

On behalf of our client, Linkage Global Inc., a Cayman Islands exempted company (the " Company "), we submit to the staff (the " Staff ") of the Securities and Exchanges Commission (the " Commission ") this letter setting forth the Company's responses to the comments contained in the Staff's letter dated December 11, 2025 on the Company's registration statement on Form F-1/A filed on October 9, 2025 (the " Registration Statement "). Concurrently with the submission of this letter, the Company is filing amendment No. 2 to Registration Statement (the " Amendment No. 2 ") via EDGAR to the Commission.

The Staff's comments are repeated below in bold and are followed by the Company's responses. We have included page references in Amendment No. 2 where the language addressing a particular comment appears. Capitalized terms used but not otherwise defined herein have the meanings set forth in Amendment No. 2.

Amendment No. 1 to Registration Statement on Form F-1

Cover Page

1. We re-issue comment 1 as to our request that you disclose the Conversion Price on the prospectus cover page.

Response: In response to the Staff's comment, the Company has revised the cover page of Amendment No. 2 to include the initial Conversion Price as of the closing date.

Prospectus Summary, Page 1

2. We re-issue comment 2 as to our request that you revise to disclose the total possible profit to be realized by the Selling Stockholder assuming the floor price.

Response: In response to the Staff's comment, the Company has revised page 8 of Amendment No. 2.

1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036 T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW

Page

If the Staff has any questions or comments concerning the foregoing, or requires any further information, please contact Ross D. Carmel, Esq. at (212) 930-9700 ext. 645 or by email at rcarmel@srfc.law. Alternatively, please contact Shane Wu, Esq. at (202) 322-8852 or by email at swu@srfc.law.

Very truly yours,
Sichenzia Ross Ference Carmel LLP

Show Raw Text
CORRESP
 1
 filename1.htm

 December 17, 2025

 Via EDGAR

 Division of Corporation Finance

 Office of Life Sciences

 Securities and Exchange Commission

 Washington, D.C. 20549

 Attn.:
 Rucha Pandit

 Mara Ransom

 Re:

 Linkage Global Inc
 Response to the Staff's Comments on
 Amendment No. 1 to Registration Statement on Form F-1
 Filed on October 9, 2025 (File No. 333-289688)

 Dear Sir and Madam:

 On behalf of our client,
Linkage Global Inc., a Cayman Islands exempted company (the " Company "), we submit to the staff (the
" Staff ") of the Securities and Exchanges Commission (the " Commission ") this letter setting
forth the Company's responses to the comments contained in the Staff's letter dated December 11, 2025 on the
Company's registration statement on Form F-1/A filed on October 9, 2025 (the " Registration
Statement "). Concurrently with the submission of this letter, the Company is filing amendment No. 2 to Registration
Statement (the " Amendment No. 2 ") via EDGAR to the Commission.

 The Staff's comments
are repeated below in bold and are followed by the Company's responses. We have included page references in Amendment No. 2 where
the language addressing a particular comment appears. Capitalized terms used but not otherwise defined herein have the meanings set forth
in Amendment No. 2.

 Amendment No. 1 to Registration Statement on Form F-1

 Cover Page

 1.
 We re-issue comment 1 as to our request that you disclose the Conversion Price on the prospectus cover page.

 Response: In response to the Staff's
comment, the Company has revised the cover page of Amendment No. 2 to include the initial Conversion Price as of the closing date.

 Prospectus Summary, Page 1

 2.
 We re-issue comment 2 as to our request that you revise to disclose the total possible profit to be realized by the Selling Stockholder assuming the floor price.

 Response: In
response to the Staff's comment, the Company has revised page 8 of Amendment No. 2.

 1185 AVENUE OF THE AMERICAS
| 31ST FLOOR | NEW YORK, NY | 10036 T (212)
930-9700 | F (212) 930-9725 | WWW.SRFC.LAW

 Page
2

 If the Staff has any questions
or comments concerning the foregoing, or requires any further information, please contact Ross D. Carmel, Esq. at (212) 930-9700 ext.
645 or by email at rcarmel@srfc.law. Alternatively, please contact Shane Wu, Esq. at (202) 322-8852 or by email at swu@srfc.law.

 Very truly yours,

 Sichenzia Ross Ference Carmel LLP

 /s/ Ross D. Carmel

 Ross D. Carmel, Esq.

 cc: Shane
Wu, Esq.